RavenQuest BioMed Inc.
RVVQF · OTC
7/31/2019 | 4/30/2019 | 1/31/2019 | 10/31/2018 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | -$0 |
| % Growth | 8.6% | 117.7% | 312.8% | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | 62.4% | -20.1% | -55% | 130.5% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -200.2% | -299.3% | -548.9% | 14,776.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -440.2% | -490.6% | -1,064.6% | 16,188.7% |
| EPS Diluted | -0.026 | -0.028 | -0.028 | -0.21 |
| % Growth | 6.1% | 1.8% | 86.5% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |